Vir Biotechnology (VIR) Other Gross PP&E Adjustments (2018 - 2025)
Historic Other Gross PP&E Adjustments for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to $35.9 million.
- Vir Biotechnology's Other Gross PP&E Adjustments fell 177.3% to $35.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.9 million, marking a year-over-year decrease of 177.3%. This contributed to the annual value of $38.0 million for FY2024, which is 5936.62% up from last year.
- As of Q3 2025, Vir Biotechnology's Other Gross PP&E Adjustments stood at $35.9 million, which was down 177.3% from $34.5 million recorded in Q2 2025.
- Vir Biotechnology's Other Gross PP&E Adjustments' 5-year high stood at $56.8 million during Q1 2024, with a 5-year trough of -$45.0 million in Q4 2021.
- Over the past 5 years, Vir Biotechnology's median Other Gross PP&E Adjustments value was $33.9 million (recorded in 2024), while the average stood at $18.7 million.
- As far as peak fluctuations go, Vir Biotechnology's Other Gross PP&E Adjustments plummeted by 102468.51% in 2021, and later surged by 45757.58% in 2023.
- Quarter analysis of 5 years shows Vir Biotechnology's Other Gross PP&E Adjustments stood at -$45.0 million in 2021, then surged by 143.47% to $19.5 million in 2022, then grew by 22.06% to $23.9 million in 2023, then soared by 59.37% to $38.0 million in 2024, then decreased by 5.57% to $35.9 million in 2025.
- Its last three reported values are $35.9 million in Q3 2025, $34.5 million for Q2 2025, and $39.9 million during Q1 2025.